Variable Total group (n = 87) HBP group (n = 45) LBBAP group (n = 42) P
Age, years 76 (64–81) 75.5 (62.5–82.5) 76 (64.2–81) .7
Sex male, n (%) 53 (60.9) 28 (62.2) 25 (59.5) .8
HT, n (%) 67 (77) 40 (89) 27 (64.3) <.01
DM, n (%) 37 (42.5) 21 (46.7) 16 (38.1) .42
Heart disease, n (%) 46 (53) 18 (40) 28 (66.7) <.05
LVEF, % 60 (35–60) 60 (34.5–60) 52.5 (34.7–60) .47
Depressed LVEF, n (%) 38 (43.7) 17 (37.8) 21 (50) .25
Dilated RA, n (%) 39 (44.8) 21 (46.7) 18 (42.9) .72
Dilated LA, n (%) 67 (77.3) 34 (75.6) 33 (78.6) .74
Previous device, n (%) 13 (15) 8 (17.8) 5 (11.9) .44
Sinus atrial rhythm, n (%) 69 (79.3) 32 (71.1) 37 (88.1) .051
PR interval, ms 196 (178–234) 192 (160–220) 200 (180–238) .28
BBB, n (%) 49 (56) 25 (55.5) 24 (57.1) .91
QRS complex, ms 145.5 ± 44 148.3 ± 48 142.5 ± 38 .54
Wide QRS complex, n (%) 55 (63.2) 28 (62.2) 27 (64.3) .84
Therapy indication .25
ABT, n (%) 51 (58.6) 29 (64.4) 22 (52.4)
CRT, n (%) 36 (41.4) 16 (35.6) 20 (47.6)